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ABSTRACT
Background and Objectives: Left ventricular (LV) midwall fractional shortening (FSmw) reflects systolic function more ac-
curately than LV endocardial fractional shortening (eFS) in patients with increased LV wall thickness. Although the normal 
reference ranges of LV-FSmw have been suggested in Western population studies, its reference values and age-related physi-
ological changes in Eastern populations remain unknown. Subjects and Methods: Conventional echocardiographic param-
eters, LV-FSmw, and stress-corrected LV-FSmw were assessed in 160 healthy and clinically normal subjects with a mean age of 
45 (range, 11-72 years; 104 males, 56 women), all of whom were confirmed to be free of disease, based on laboratory investiga-
tions, clinical and physical examination findings and computed tomographic coronary angiographic examinations. Results: 
LV-FSmw was higher in women compared to men. However, the differences were without statistical significance (18.2±1.5% 
for male gender and 19.4±2.5% for female gender, p=0.07). In contrast to LV-eFS that progressively increased with age 
(p=0.001), LV-FSmw and stress-corrected LV-FSmw was not influenced by changes in age (p=0.88 and 0.29, respectively). 
The results remained unchanged when analyses were performed adjusting for gender. Conclusion: The results of this study 
provide normal reference values for LV-FSmw and stress-corrected LV-FSmw and their natural physiological changes with ad-
vancing age. These measures can be used as reference standards for research on LV systolic function in the setting of pressure 
or volume overload. (Korean Circ J 2010;40:587-592)
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Introduction 
The assessment of left ventricular (LV) systolic function is 
of vital importance because it is closely associated with fu-
ture patient outcomes.
1)2) Evaluation of LV systolic function 
is usually achieved by measuring the ejection fraction (EF) 
and fractional shortening (FS). Albeit useful, the EF and FS 
obtained by conventional approach are derived from endo-
cardial movement. As such, they cannot reliably reflect the 
“actual” systolic function in the setting of increased LV wall th-
ickness.
3) In fact, LV systolic function measured by conven-
tional EF or endocardial FS (eFS) in patients with LV hyper-
trophy is estimated to be almost always normal or supernor-
mal in spite of the adverse prognosis of patients with LV hy-
pertrophy.
4) This paradoxical trend may be explained by the 
followings: first, the inner layer of the LV that includes the en-
docardium moves inward, further than the outer layer of the 
LV. Second, the inner layer of the “thickened” LV tends to show 
more inward movement during systole, compared to the in-
ner layer of the LV with “normal” thickness.
5) Therefore, it has 
been recommended that the LV midwall FS (LV-FSmw) be 
used in place of conventional eFS in patients with increased 
LV wall thickness for the assessment of LV systolic perform-
ance.
6) From a prognostic point of view, LV-FSmw has prov-
en its value as a predictor of cardiac death and cardiovascular 
morbidity in patients with arterial hypertension.
6)7) Any gen-
eral use of LV systolic functional parameters should be pre-588   Normal Reference of LV Midwall Fractional Shortening
ceded by determining their normal reference ranges. As the 
number and proportion of older individuals progressively in-
crease in the general population, knowledge of the normal re-
ference ranges and the physiological changes associated with 
aging will become important. Although the normal reference 
ranges for LV-FSmw have previously been established by st-
udies in the Western population,
8)9) the reference values and 
physiological changes with age have yet been explored in the 
Asian populations. 
The objective of this study was to determine the normal 
reference values and physiologic changes of LV-FSmw, based 
on 160 clinically normal Koreans and utilize the outcomes to 
establish reference standards for the assessment of LV-FSmw 
in patients with pressure or volume overload in future studies.
Subjects and Methods 
Study population
Volunteers who visited the Health Care Center at our hospi-
tal for general routine check-up without laboratory abnor-
malities, including electrocardiographic and echocardiogra-
phic findings, were considered candidates for this study. Pa-
tients with a history of cardiovascular or systemic diseases were 
excluded. For inclusion, subjects less than 40 years of age had 
to undergo a modified Bruce protocol-based treadmill test and 
those beyond 40 years of age required a treadmill test and a 
computed tomographic coronary angiography (CTCA) in or-
der to exclude subclinical coronary artery disease. Volunteers 
who had stenosis of >25% in any coronary artery on the CTCA 
and who did not reach at least 85% of age-predicted maximal 
heart rate during the treadmill test were systematically exclud-
ed. Subjects who were ≥50 years of age were screened by ca-
rotid Doppler examination and patients who had stenoses gr-
eater than 50% of the lumen diameter in any carotid arteries 
were excluded. The study protocol was approved by the insti-
tutional review board of our hospital and written informed con-
sent was obtained from all participants before study enrollment.
Echocardiographic analysis
Echocardiographies were performed by one cardiologist 
using commercially available equipment (GE Vivid 7, GE me-
dical systems, Milwaukee, WI, USA) with subjects in the left 
lateral decubitus position. LV cavity size, LV mass, LV relative 
wall thickness (RWT) and FSmw were determined using tis-
sue harmonic imaging with M-mode measurements accord-
ing to the guidelines suggested by the American Society of Echo-
cardiography.
10) Interventricular septal wall thickness (IVST), 
LV internal diameter (LVID) and posterior wall thickness 
(PWT) were measured at end-diastole and at end-systole. LV 
mass was calculated with the Devereux formula.
11) To estab-
lish the relationship between LV mass and linear height (Ht), 
LV mass was adjusted for height by dividing the value by the 
Ht
2.7.
12) LV-RWT was calculated using (LV-IVSTd+LV-PWTd)/ 
LVIDd. The LV-eFS was calculated using the conventional for-
mula: e.g., LV-eFS (%)={(LVIDd-LVIDs)/LVIDd}×100, where 
s denotes end-systole and d, end-diastole. LV-EF was derived 
from modified Simpson’s method. 
Left ventricular midwall fractional shortening 
calculation
Calculation of LV-FSmw was performed with the assump-
tion of a cylindrical shaped LV, including consideration of epi-
cardial migration of midwall circumferential fibers during 
systole.
13) The model that assumed LV geometry to be cylindri-
cal shaped considered LV as the union of two concentric cylin-
drical shells, with equal thickness at end-diastole (Fig. 1). This 
model is based on the fact that LV wall volume is constant dur-
ing the cardiac cycle. Using this model, the LV-FSmw can be 
calculated with the following formula: LV-FSmw={(LVIDd+ 
LV-IVSTd/2+LV-PWTd/2)-(LVIDs+Hs/2)}/LVIDd+LV-
IVSTd/2+LV-PWTd/2) 
 
Stress-corrected left ventricular midwall fractional
shortening calculation
In order to eliminate the effects of LV afterload on LV-
FSmw, stress-corrected LV-FSmw was calculated by normal-
izing LV-FSmw to LV circumferential end-systolic wall stress 
(LV-cESS) in each subject.
14) LV-cESS was calculated from 
the following formula: LV-cESS={[SBP×(LVIDs/2)
2]×[1+(L
VIDs/2+LV-PWTs)
2/(LVIDs/2+LV-PWTs/2)
2]}/{(LVIDs/ 
2+LV-PWTs)
2-(LVIDs/2)
2}, where SBP is the brachial cuff 
systolic blood pressure (BP). 
Epicardium
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Fig. 1. Schematic representation of two shell geometry model of midwall. Hd: diastolic thickness of shell, Hs: systolic thickness of shell.Kyungil Park, et al.   589
Statistical analysis
All measurements were analyzed by one observer using St-
atistical Package for the Social Sciences (SPSS) statistical soft-
ware, version 14.0 (SPSS, Inc., Chicago, IL, USA). Data are pre-
sented as the mean±SD for continuous variables and number 
(percentages) for categorical variables. To minimize the im-
pact of confounding factors due to the increased proportion 
of women in the older age group, partial correlation and anal-
ysis of covariance taking gender into account were performed. 
A p<0.05 was considered statistically significant.
Results
Clinical and conventional echocardiographic data
The study population was comprised of 160 subjects {104 
males, 56 womens, age 44.9±2.7 years (range, 11-72 years)}. 
Clinical and conventional echocardiographic results across age 
deciles are summarized in Table 1. 
Comparison of left ventricular-endocardial fractional 
shortening and left ventricular midwall fractional 
shortening without gender breakdown
Table 2 shows the comparison between eFS and FSmw, with 
differentiation by age deciles in conjunction with data for the 
entire cohort. LV mass/Ht
2.7 and LV-RWT showed significant 
increases with age (p for trend=0.002 and 0.001, respectively). 
LV-eFS and LV-EF also displayed a gradual increase with age 
(p for trend=0.001 and 0.002, respectively), whereas LV-FSmw 
and SC LV-FSmw remained constant, regardless of age (p for 
trend=0.88 and 0.29, respectively). 
Comparison of left ventricular-endocardial fractional 
shortening, left ventricular midwall fractional 
shortening and stress-corrected left ventricular 
midwall fractional shortening according to gender
Echocardiographic findings of endocardial versus midwall 
mechanics by gender are shown in Table 3 and 4. Although 
the analyses were limited by small sample size, LV-RWT and 
LV-eFS showed significant increase, in parallel with age among 
men (p for trend=0.001 and 0.006, respectively) and women (p 
for trend=0.030 and 0.014, respectively). With advancing age, 
LV-FSmw tended to decrease, without statistical significance 
in men (p for trend=0.30). Despite a slightly higher LV-FSmw 
value in women compared to men (18.2±1.5% for male vs. 
19.4±2.5% for female), this difference did not reach statisti-
cal significance (p=0.07). In the women, LV-FSmw showed no 
trend in the relationship with age (p for trend=0.99), as shown 
in Table 4. SC LV-FSmw value also showed no trend with age 
Table 1. Clinical and conventional echocardiographic data  
Total
(n=160)
Group 1
(≤30 years)
(n=29)
Group 2
(31-40 years)
(n=26)
Group 3
(41-50 years)
(n=50)
Group 4
(51-60 years)
(n=35)
Group 5
(≥ 61 years)
(n=20)
p
Clinical profiles
    Male (%) 104 (65.0) 22 (75.9) 20 (76.9) 31 (62.0) 18 (51.4) 13 (65.0) <0.20
    Weight (kg) 0064.1±10.3 0065.1±11.7 0066.9±10.2 0065.3±10.2 061.9±8.60. 0060.1±10.6 <0.11
    Height (cm) 166.5±8.1 170.4±8.3 169.1±5.5 166.2±7.9 163.1±7.0*0 164.4±9.7 <0.001
    Heart rate (/min) 066±11 0068±11 0068±11 00.65±10 00.64±9000 00.69±13 <0.17
    SBP/DBP (mmHg)
0.115±13/
0077±10
0.113±15/
00.70±10
0.116±17/
00.78±11
0.111±11/
00.76±10
0.118±13/0.
00.78±1000
0.117±12/
00.77±10
<0.30/
<0.50
    QRS duration on EKG (msec) 0093.6±12.1 0085.7±17.6 094.8±9.9 0.95.6±9.3† 097.0±10.5* 092.6±9.2 <0.001
Echocardiographic data
    M-mode parameters
        LVIDs (mm) 029.5±4.1 031.5±4.2 030.3±3.8 030.0±3.7 27.3±4.1* 028.4±3.6 <0.001
        LVIDd (mm) 047.8±4.4 049.0±4.9 047.8±4.0 048.4±4.3 46.5±4.00 046.4±4.6 <0.10
        IVSd (mm) 008.9±1.2 008.4±1.2 008.8±1.3 009.1±1.2 9.2±1.2 008.9±1.0 <0.10
        LVPWd (mm) 008.6±1.3 008.0±1.3 008.0±1.3 008.7±1.4 09.1±1.3† 008.8±0.9 <0.003
        LV mass/Ht
2.7 (g/m
2.7) 035.9±7.7 032.1±5.5 033.2±8.0 037.5±7.1† 38.7±8.0† 036.4±8.6 <0.002
    2D parameters
        LVESV (mL) 0035.9±10.3 0042.6±11.2 038.8±8.6 036.2±9.9 030.5±6.9*
‡ 0030.5±9.9* <0.001
        LVEDV (mL) 0098.8±21.3 0111.8±23.7 0102.8±20.0 0099.3±19.2 089.9±15.9* 00087.5±21.7* <0.001
        LVEF (%) 064.0±4.8 062.3±4.0 062.2±4.0 063.8±5.4 066.2±4.2 †‡ 065.5±4.7 <0.002
*p<0.01 versus Group 1, †p<0.05 versus Group 1, ‡p<0.05 versus Group 2. S(D)BP: systolic (diastolic) blood pressure, EKG: electrocardiogram, 
LVIDs(d): left ventricular systolic (diastolic) dimension, IVSd: diastolic interventricular septal thickness, LVPWd: diastolic left ventricular poste-
rior wall thickness, LVES(D)V: left ventricular end-systolic (diastolic) volume, LVEF: left ventricular ejection fraction590   Normal Reference of LV Midwall Fractional Shortening
(p for trend= 0.29 for male and 0.50 for female).
Discussion 
This is the first report on the normal reference values of LV-
FSmw and the natural, physiological changes with age in a 
large number of healthy Korean individuals who underwent 
echocardiography using the harmonic imaging technique. In 
contrast to LV-eFS that showed a progressive increase in par-
allel with age, LV-FSmw displayed no significant changes in 
relation to aging in all subjects. This remained the case even 
when the analyses were performed to adjust for gender. Over-
all, the LV-FSmw values obtained in this study were compa-
rable to that of previous studies.
9)15) However, the trend for LV-
FSmw change is different from that of previous studies, in which 
LV-FSmw decreased slightly with advancing age in normal 
subjects.
9)15) This discrepancy can be explained by differences 
in the characteristics of the study population. Specifically, the 
Table 2. Comparison of LV-eFS and LV-FSmw in the entire study cohort
Total
(n=160)
Group 1
(≤30 years)
(n=29)
Group 2
(31-40 years)
(n=26)
Group 3
(41-50 years)
(n=50)
Group 4
(51-60 years)
(n=35)
Group 5
(≥61 years)
(n=20)
p for 
trend
LV mass/Ht
2.7 (g/m
2.7) 035.9±7.7 032.1±5.5 033.2±8.0 037.5±7.1† 038.7±8.0† 036.4±8.6 0.001
LV-RWT (cm) 00.37±0.06 00.34±0.06 00.35±0.05 00.37±0.06 00.39±0.05† 00.39±0.06† 0.001
LV-eFS (%) 038.3±4.8 035.9±3.1 036.9±4.6 038.1±4.0 041.4±5.5*
§ 038.8±5.2 0.001
LV-FSmw (%) 018.6±2.0 018.6±1.6 018.5±1.8 018.6±2.0 018.9±2.4 018.3±2.2 0.880
cESS (kdyne/cm
2) 123.5±27.9 138.7±31.9 133.7±36.3 121.6±27.9 117.0±24.5 123.9±20.5 0.101
SC LV-FSmw 
  (cm
2/kdyne ∙ 10
-2)
015.9±4.3 014.5±3.3 014.7±4.7 016.2±4.4 017.1±4.8 014.8±2.7 0.618
*p<0.01 versus Group 1, †p<0.05 versus Group 1, §p<0.01 versus Group 2. LV: left ventricle, RWT: relative wall thickness, eFS: endocardial frac-
tional shortening, FSmw: mid wall fractional shortening, cESS: circumferential end-systolic wall stress, SC LV-FSmw: stress-corrected mid wall 
fractional shortening
Table 3. Comparison of LV-eFS and LV-FSmw in male subjects
Total
(n=104)
Group 1
(≤30 years)
(n=22)
Group 2
(31-40 years)
(n=20)
Group 3
(41-50 years)
(n=31)
Group 4
(51-60 years)
(n=18)
Group 5
(≥61 years)
(n=13)
p for 
trend
LV mass/Ht
2.7 (g/m
2.7) 036.7±6.9 033.3±5.4 034.2±7.3 039.3±6.3† 040.3±6.8† 034.7±6.7 0.024
LV-RWT (cm) 00.37±0.06 00.34±0.06 00.35±0.05 00.38±0.06† 00.40±0.04†‡ 00.38±0.05 0.001
LV-eFS (%) 037.3±4.2 035.4±3.2 036.4±4.4 037.5±3.7 040.2±5.1* 037.2±3.8 0.006
LV-FSmw (%) 018.2±1.5 018.5±1.4 018.3±1.3 017.9±1.6 018.1±1.6 018.0±1.8 0.296
cESS (kdyne/cm
2) 127.9±28.1 148.5±23.6 139.5±30.3 123.9±28.4 119.0±28.9 132.2±19.2 0.123
SC LV-FSmw 
  (cm
2/kdyne ∙ 10
-2)
014.9±3.7 013.6±2.8 013.7±3.2 015.4±3.9 016.2±4.3 013.7±2.1 0.497
*p<0.01 versus Group 1, †p<0.05 versus Group 1, ‡p<0.05 versus Group 2. LV: left ventricle, RWT: relative wall thickness, eFS: endocardial frac-
tional shortening, FSmw: mid wall fractional shortening, cESS: circumferential end-systolic wall stress, SC LV-FSmw: stress-corrected mid wall 
fractional shortening
Table 4. Comparison of LV-eFS and LV-FSmw in female subjects
Total
(n=56)
Group 1
(≤30 years)
(n=7)
Group 2
(31-40 years)
(n=6)
Group 3
(41-50 years)
(n=19)
Group 4
(51-60 years)
(n=17)
Group 5
(≥61 years)
(n=7)
p for 
trend
LV mass index (g/m
2) 034.6±8.9 28.3±4.3 029.9±9.8 034.5±7.6 037.0±8.9 039.4±11.2 0.003
LV-RWT (cm) 00.37±0.06 0.34±0.06 00.35±0.07 00.35±0.06 00.38±0.06 00.40±0.08 0.030
LV-eFS (%) 040.3±5.2 37.5±2.4 038.3±5.4 039.2±4.4 042.8±5.7 041.6±6.4 0.014
LV-FSmw (%) 019.4±2.5 19.2±2.1 019.1±3.0 019.6±2.2 019.6±2.8 018.7±2.8 0.991
cESS (kdyne/cm
2) 111.0±27.9 89.7±21.3 122.3±47.9 117.0±27.4 113.2±14.4 110.4±15.6 0.726
SC LV-FSmw 
  (cm
2/kdyne ∙ 10
-2)
018.8±6.8 18.8±2.5 016.8±6.8 017.9±5.0 017.2±2.2 016.7±2.8 0.680
LV: left ventricle, RWT: relative wall thickness, eFS: endocardial fractional shortening, FSmw: mid wall fractional shortening, cESS: circum-
ferential end-systolic wall stress, SC LV-FSmw: stress-corrected mid wall fractional shorteningKyungil Park, et al.   591
subjects in the present study exhibited no increment in BP with 
age, whereas BP of the subjects enrolled in the study by Slot-
winter et al.
9) displayed stepwise BP increment in parallel 
with age, which can lead to a significant discrepancy between 
the two studies. In addition, silent myocardial diseases may ac-
count for some of the modest age-related decline in LV-FSmw 
observed in previous studies,
15) which was not the case for our 
study due to systematic exclusion of subjects with subclinical 
coronary artery disease based on treadmill test and CTCA. We 
believe that this attempt is of crucial value, given that coro-
nary artery disease is now the most common cause of subcli-
nical myocardial dysfunction in Korea. In terms of conven-
tional echocardiographic parameters, LVIDs, LVIDd, LV-
IVSd, and LV-PWTd values in patients less than 50 years are 
comparable to that obtained in previous studies, albeit there 
exist discrepancies in subjects aged more than 50 years.
16) How-
ever, the differences are very small and can be considered wi-
thin a variability range that may be observed in routine echo-
cardiographic examinations.
Echocardiography is a non-invasive and readily available dia-
gnostic modality that performed in patients with known or 
suspected cardiovascular disease. Thanks to its versatility, the 
indications for echocardiography have progressively expand-
ed. The assessment of LV systolic function is one of the most 
important clinical applications of echocardiography. Tradi-
tionally, echocardiographic evaluation of LV systolic func-
tion has been predicated using indexes acquired by measure-
ments at the endocardial level. Many previous studies have 
shown that assessment of the LV systolic function based on 
endocardial movement affected the choice and timing of car-
diac surgery and long-term survival.
17)18) However, LV systolic 
function obtained on the basis of endocardial movement is 
of limited utility in patients with LV hypertrophy, given the re-
ciprocal change of LV-EF in relation to LV wall thickness.
19)20) 
In other words, the presence of ventricular hypertrophy can 
lead to over-estimation of LV-EF, the most frequently used in-
dex for estimating LV systolic performance, despite decline 
in myocardial function, as demonstrated by tagging magne-
tic resonance imaging.
21) This apparent discrepancy could be 
explained, at least in part, by “cross-fiber shortening”, where 
endocardial shortening tends to be greater than normal in 
patients with LV hypertrophy.
22) Because subendocardial fibers 
are longitudinally arranged, circumferential and radial short-
ening observed at the endocardial level cannot be directly 
generated by shortening of subendocardial fibers per se. 
To overcome the limitation of evaluating LV systolic func-
tion in patients with thickened LV walls, direct estimation of 
LV-FSmw was introduced and found to be physiologically 
more appropriate than LV-eFS in estimating LV systolic per-
formance when LV hypertrophy was present.
3)6) Furthermore, 
LV-FSmw was shown to be an independent risk factor to 
predict cardiovascular events in patients with hypertension.
23-26) 
As the number and proportion of older individuals in the 
population progressively increases, the prevalence of hyper-
tensive patients is expected to increase steadily and thus the 
utility of LV-FSmw could be augmented. For widespread use 
of LV-FSmw in the clinical arena, knowledge of its normal re-
ference range and physiologic changes associated with aging 
become more and more pivotal.
This study, for the first time, demonstrated the normal re-
ference ranges of LV-FSmw and its physiological changes with 
age in the Asian population. Cardiovascular disease states can 
only be characterized in the aging populations with reference 
to age-adjusted normal values. However, in terms of defining 
normal reference ranges, the sole effect of aging on natural re-
modeling of the heart is difficult to evaluate, because of sub-
clinical diseases not infrequently found in clinical practice in-
cidentally. Because all individuals in the present study were 
confirmed to be clinically normal based on laboratory tests, 
clinical and physical examination findings, CTCA and ca-
rotid Doppler studies, we believe that our study is free of in-
advertent enrollment of patients with subclinical disease.
It is interesting to note that in the current study, LV-FSmw 
obtained in male subjects showed slightly higher values com-
pared to the females, although the difference did not reach sta-
tistical significance (19.4±2.5% vs. 18.2±1.5%, p=0.068). In 
addition, while LV-eFS increased in a stepwise manner with 
age, LV-FSmw did not significantly vary by the age deciles, 
suggesting that age per se does not necessarily needed to be 
considered when interpreting LV-FSmw, which is useful in 
the clinical application of LV-FSmw when comparison is made 
between groups with different ages. This result is also sup-
ported by the fact that no changes were observed in stress-cor-
rected LV-FSmw with age, which was performed to eliminate 
the influence of LV afterload on LV-FSmw.
There were several limitations to this study. First, our data 
was derived from a single center and they may not be directly 
applicable to general populations. Normal echocardiographic 
range of any specific parameter population should be derived 
from a random sample of the general population. In this re-
spect, our population may not reflect the general population. 
However, we selected healthy subjects among the population 
who visited our health care center for general check-up at their 
discretion. Therefore, we believe that the present study popu-
lation can be, to some extent, a representative sample of the 
Koreans. 
In conclusion, the results of this study provide normative 
data for LV-FSmw and its physiological changes with age in 
a relatively large number of normal Asian subjects. LV-FSmw 
remained stable with age, which was in contrast to LV-eFS 
that showed progressive increase in parallel with age. The in-
formation obtained in the present study can be applicable to 
future studies, and provides reference standards with which 
LV systolic dysfunction can be defined more accurately.592   Normal Reference of LV Midwall Fractional Shortening
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